Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.hrtlng.2021.02.009 http://scihub22266oqcxt.onion/10.1016/j.hrtlng.2021.02.009 33621840!7874976!33621840     free     free     free       Heart+Lung 2021 ; 50 (3): 425-429 Nephropedia Template TP {{tp|p=33621840|t=2021. Impact of HFNC application on mortality and intensive care length of stay in acute respiratory failure secondary to COVID-19 pneumonia |pdf=|usr=}}{{33621840}} gab.com Text Impact of HFNC application on mortality and intensive care length of stay in acute respiratory failure secondary to COVID-19 pneumonia JO: Heart Lung http://www.kidney.de/pget.php?&tw=1&pmid=33621840 #FOAvip BACKGROUND: In Covid-19 pneumonia, high mortality rates reported in intubated patients have raised non-invasive methods of respiratory support. OBJECTIVE: We aimed to evaluate the impact of HFNC application on intubation requirement, intensive care length of stay, and short-term mortality in patients with COVID-19 pneumonia. MATERIAL-METHOD: Patients receiving oxygen by reservoir mask or HFNC therapy in our intensive care units due to COVID-19 pneumonia were included in the study. Group H consisted of patients who received HFNC, and Group K consisted of patients who received conventional oxygen therapy (COT). The number of patients intubated, duration of intensive care stay and short-term mortality were recorded. RESULTS: 43 patients were included. The short-term mortality and the number of patients with intubation need was lower in Group H. There was no significant difference between the Groups in the length of intensive care stay. CONCLUSION: Administration of HFNC in respiratory failure secondary to COVID-19 pneumonia decreases the need for intubation and mortality. Twit Text FOAVip Impact of HFNC application on mortality and intensive care length of stay in acute respiratory failure secondary to COVID-19 pneumonia ????Heart Lung http://www.kidney.de/pget.php?&tw=1&pmid=33621840 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33621840 #FOAvip English Wikipedia <ref>{{Cite pmid|33621840}}</ref> Impact of HFNC application on mortality and intensive care length of stay in acute respiratory failure secondary to COVID-19 pneumonia #MMPMID33621840 Sayan I; Altinay M; Cinar AS; Turk HS; Peker N; Sahin K; Coskun N; Demir GD Heart Lung 2021[May]; 50 (3): 425-429 PMID33621840show ga BACKGROUND: In Covid-19 pneumonia, high mortality rates reported in intubated patients have raised non-invasive methods of respiratory support. OBJECTIVE: We aimed to evaluate the impact of HFNC application on intubation requirement, intensive care length of stay, and short-term mortality in patients with COVID-19 pneumonia. MATERIAL-METHOD: Patients receiving oxygen by reservoir mask or HFNC therapy in our intensive care units due to COVID-19 pneumonia were included in the study. Group H consisted of patients who received HFNC, and Group K consisted of patients who received conventional oxygen therapy (COT). The number of patients intubated, duration of intensive care stay and short-term mortality were recorded. RESULTS: 43 patients were included. The short-term mortality and the number of patients with intubation need was lower in Group H. There was no significant difference between the Groups in the length of intensive care stay. CONCLUSION: Administration of HFNC in respiratory failure secondary to COVID-19 pneumonia decreases the need for intubation and mortality. |*COVID-19[MESH] |*Respiratory Insufficiency/etiology/therapy[MESH] |Cannula[MESH] |Critical Care[MESH] |Humans[MESH] |Length of Stay[MESH] |Oxygen Inhalation Therapy[MESH]Impact of HFNC application on mortality and intensive care length of s(epmc).pdf DeepDyve Pubget Overpricing